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Summary
Background: Joint space width (JSW) evaluated in millimeters on plain X-rays is the currently optimal recognized technique to evaluate
osteoarthritis (OA) structural progression. Data obtained can be presented at the group level (e.g., mean standard deviation of the changes).
Such presentation makes difﬁcult the interpretation of the clinical relevance of the reported results. Therefore, a presentation at the individual
level (e.g., % progressors) seems more attractive but requires to determining a cut-off. Several methodologies have been proposed to deﬁne
cut-offs in JSW: arbitrary chosen cut-off, cut-off based on the validity to predict a relevant end-point such as the requirement of total articular
replacement or cut-off based on the measurement error such as smallest detectable difference (SDD).
Objectives: The objective of this OARSIeOMERACT initiative was to deﬁne a cut-off evaluated in millimeters on plain X-rays above which
a change in JSW could be considered as relevant in patients with hip and knee OA.
Methods: The ﬁrst step consisted in a systematic literature research performed using Medline database up to July 2007 to obtain all manu-
scripts published between 1990 and 2007 reporting a cut-off value in JSW evaluated in millimeters at either the knee or hip level. The second
step consisted in a consensus based on the best knowledge of the 11 experts with the support of the available evidence.
Results: Among the 506 articles selected by the search, 47 articles reported cut-off of JSW in millimeters. There was a broad heterogeneity in
cut-off values, whatever the methodologies or the OA localization considered (e.g., from 0.12 to 0.84 mm and from 0.22 to 0.78 mm for Knee
(seven studies) and hip (seven studies), respectively when considering the data obtained based on the reliability). Based on the data extracted
in the literature, the expert committee proposed a deﬁnition of relevant change in JSW based on plain X-rays, on an absolute change of JSW in
millimeters and on the measurement error e.g., calculation of the SDD using the Bland and Altman technique. The results of the analysis of
JSW should be expressed in terms of a dichotomous variable (e.g., progressors yes/no): a patient with a change in JSW during the study over
such SDD will fulﬁll the deﬁnition of ‘‘progressor’’. Moreover, the pilot study aimed at evaluating the measurement error should be designed to
reﬂect the different characteristics of the primary study in which the analysis of the radiological ﬁndings will be based on (patient’s character-
istics, centers characteristics, readers).
Conclusion: This initiative based on both an Evidence Based Medicine (Systematic Literature Research) and Expert Opinion approach re-
sulted in a proposal of deﬁnition of relevant radiological progression in OA to be used as end-point in clinical trials and also recommendations
on the conduct of the reliability study allowing such deﬁnition.
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857Osteoarthritis and Cartilage Vol. 17, No. 7Osteoarthritis (OA) is a major cause of disability worldwide
and has a signiﬁcant impact on the patients’ health-related
quality of life. With the development of disease modifying
OA drugs (DMOADs) with a potential structure-modifying ef-
fect, technologies such as plain radiographs and/or mag-
netic resonance imaging (MRI) are used to assess
structural progression in hip and knee OA. Using these
imaging techniques, several therapeutical trials have
recently reported signiﬁcantly slower structural progression
for patients receiving various DMOADs compared to pla-
cebo. The medical community is not yet convinced of the
clinical relevance of such results.
The capacity of a drug to prevent or to delay a hard clin-
ical end-point such as the requirement of total articular
replacement might be considered more relevant. This
end-point has been criticized because the decision to per-
form total articular replacement is inﬂuenced by the severity
of pain and functional limitation due to OA, covariates such
as age, co-morbidities, and the patient’s willingness to un-
dergo the procedure. This criticism has led to the sugges-
tion that the appropriate end-point might be the time to
fulﬁll the criteria for considering total articular replacement
rather than time to the actual surgery1. In 2004, OARSI (Os-
teoarthritis Research Society International) and OMERACT
(Outcome Measures in Rheumatology) agreed to set-up
a task force to establish a set of criteria to determine if a pa-
tient qualiﬁed for total articular replacement (knee/hip). The
set of criteria would be used as an end-point in clinical trials
evaluating potential DMOADs1. It was anticipated that these
criteria would reﬂect the three main domains, i.e., pain,
functional impairment and structural damage2 and would
be combined into an overall index. Consequently, the task
force was sub-divided among three sub-tasks:
B a sub-task force to propose a tool to evaluate pain;
B a sub-task force to propose a tool to evaluate function;
B a sub-task force to propose a tool to evaluate structure.
The proposed tools to evaluate these criteria would have
to fulﬁll the OMERACT ﬁlter i.e., truth, discrimination and
feasibility. In December 2006, the sub-task force on struc-
ture ﬁnished evaluating validated measures of joint damage
and concluded that, at the present time, joint space width
(JSW) on a plain X-ray expressed in millimeters was optimal
for use in OA clinical trials, at least for the next few years, to
evaluate the severity of structural damage3. However, JSW
expressed in millimeters is a continuous variable that does
not make it possible to classify patients as ‘‘progressors’’ or
non-‘‘progressors’’ based on changes in JSW. In fact, it is
more clinically relevant to express the results of analyses
in terms of individual patients. For example, the percentage
of individual patients who have structural progression dur-
ing a study is more meaningful than the average change
in JSW. Therefore the composite index based on the set
of criteria should be deﬁned at the individual level, i.e.,
a cut-off for change in JSW above which a patient would
be classiﬁed as a ‘‘progressor’’.
Based on the conclusion of the above mentioned sub-task
force, the objective of the present OARSIeOMERACT initia-
tivewas to determinea cut-off expressed inmillimeters above
which a change in JSW evaluated on plain X-rays would be
considered relevant in patients with hip and knee OA.Methods
Relevant change in JSW in patients with hip or knee OA was determined
in a two-step procedure. The ﬁrst step was a systematic literature search andthe second step was a consensus based on the opinion of the OARSI ex-
perts after reviewing the available evidence.SYSTEMATIC LITERATURE SEARCHSelection process
The Medline database was systematically searched through July 2007 to
obtain all manuscripts published between 1990 and 2007 reporting a cut-off
value for JSW expressed in millimeters for either the knee or hip. The initial
search was performed in May 2007 using the following combination of key
words ‘‘Osteoarthritis AND (Hip or Knee) AND joint space’’. The following
limits were used: human and reports published between 1990 and 2007.
In addition, Reference sections of the papers initially detected were further
searched manually to identify additional relevant reports. Subsequently, reg-
ular updates were performed up to July 2007. From the resulting initial pool
of abstracts, only articles reporting a cut-off for JSW expressed in millimeters
on plain X-rays over any set interval of time were ﬁnally retained. Reviews,
guidelines, editorials and case reports were excluded as well as articles
based on secondary hip or knee OA.
Cut-offs methodologies
Several approaches can be used to determine a cut-off point above which
changes in JSW observed during a study would be considered indicative of
radiological progression. Signiﬁcant progression can be deﬁned on the basis
of:
e An intuitive global assessment of disease progression given by an
expert, based on knowledge of and experience with disease
progression.
e Statistical methods based on measurement error involved calculating
the mean of the differences between two analyses to evaluate reliabil-
ity, expressed as either:
B The coefﬁcient of variation (CV), deﬁned as the standard deviation
(SD) of a set of JSW measurements multiplied by 100 and divided
by their mean.
B The smallest detectable difference (SDD): in the Bland and Altman
method, for each patient, the change from the baseline to the post-
treatment JSW assessment is plotted against the mean of the two
assessments including the limits of agreement (deﬁned as mean
change 1.96 SD of the change). A change in JSW over time
greater than the SDD, i.e., 1.96SD of the change from baseline
to post-treatment measurements (cut-off point), probably reﬂects
organic change4. Thereafter, a radiological relevant change is
deﬁned by a change which is over this measurement error.
e Predictive models based on evidence derived through the predictive
validity of an outcome measure (on the basis of maximal sensitivity
and speciﬁcity using receiver operating characteristic (ROC) curve
analysis): for example, determination of a cut-off point above which
a change in JSW could be considered clinically relevant in patients
with knee/hip OA on the basis of the prediction of subsequent total ar-
ticular replacement.
Moreover, it was anticipated that cut-offs used might differ between ran-
domized controlled trials (RCT) and longitudinal epidemiological studies.
Data extraction
The full text of each retained article was reviewed and the reviewer (PO)
extracted the following information: ﬁrst author, year of publication, journal
name, impact factor, localization (hip/knee), proposed cut-off and methodol-
ogies used to determine the cut-off. For RCT and epidemiological studies,
study duration and percentage of progressors were also extracted. For arti-
cles in which the cut-off was based on a measurement error approach,
methods for evaluation of reliability (e.g., SDD or CV) and radiographic pro-
cedure were also extracted.
Because of the heterogeneity of the studies, populations and radiological
techniques by which JSW was measured, the results (population data and
cut-off value) were not pooled.EXPERT OPINIONThe steering committee comprised 11 experts (i.e., senior researchers),
one librarian (GUW) and one research fellow (PO) from four countries. All
of the experts have been involved in OA longitudinal epidemiological stud-
ies and/or OA clinical trials and in radiographic assessment of OA for
many years. The results of the literature search were summarized and
disseminated to the expert committee. Based on their discussion of the
literature review, the OARSI experts proposed a cut-off expressed in mil-
limeters above which a radiological change in JSW could be considered
relevant in patients with hip and knee OA participating in a clinical trial.
PubMed Search (July 2007)
Osteoarthritis AND (hip or knee) AND joint space
Limits: Publication Date from 1990 to 2007, Humans 
n = 504
Articles excluded on abstract:
n = 335 
-  review n = 64 
-  No joint space data n = 55
 
-  Cross-sectional study n = 72 
-  Not primary OA n = 17 
-  Patello-femoral data n = 45
-  Surgery data  n = 75
-  Others n = 7
n = 169
Clinical trials
with X-rays data
n = 43
Epidemiological studies
with X-rays data
n = 65
 
Cut-offs determined 
by reliability
n = 58   
Predictive
validity
n = 3 
n = 22 n = 58 n = 24
Articles excluded on full text:
n = 21 
-  Double n = 12 
-  Reliability from RCT n = 7 
-  Cohort n = 1 
-  No JSW data n = 1
-  No JSW data n = 2
Articles excluded on full text:
n = 7 
 
-  Double n = 5 
Articles excluded on full text:
n = 34
-  Double n = 7 
-  No SDD or CV data n = 21
 
-  No JSW data n = 6
Hip OA
JSW
n = 4
with JSW
in mm
n = 3
Hip JSW
cut-off
n = 2
Knee OA
JSW
n = 18
with JSW
in mm
n = 17
Knee JSW
cut-off
n = 8
Hip OA
JSW
n = 10
with JSW
in mm
n = 6
Hip JSW
cut-off
n = 4
Knee OA
JSW
n = 48
with JSW
in mm
n = 26
Knee JSW
cut-off
n = 7
Hip OA
n = 7
Hip JSW
SDD
n = 7
Knee OA
n = 17
Knee JSW 
SDD 
n = 16 
Knee JSW
cut-off
n = 1
Hip JSW
cut-off
n = 2
Knee OA
JSW
n = 1
Hip OA
JSW
n = 2
Fig. 1. Flow chart: manuscripts selection process.
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859Osteoarthritis and Cartilage Vol. 17, No. 7ResultsSYSTEMATIC LITERATURE SEARCHThe results of the manuscript selection process are
reported in Fig. 1. Results from RCT and epidemiological
studies (Tables I and II) where developing a cut-off (based
on intuitive expert opinion or based on reliability) was sec-
ondary to other objective are separated from results of
studies whose only purpose was to establish a cut-off
(based on predictive validity (Table III) or reliability (Tables IV
and V)).
The systematic search identiﬁed 504 publications re-
lated to hip or knee OA and joint space. After abstract
and title review, 169 manuscripts were further evaluated
concerning radiological change in JSW. They included re-
ports of RCT (43), cohort studies (65), and studies evalu-
ating reliability (58) or predictive validity (3). Another 122
articles were withdrawn during this process (Fig. 1),
most of which did not report a JSW cut-off in millimeters,
leaving a ﬁnal group of 47 articles which reported a JSW
cut-off in millimeters, among which half were based on the
measurement error approach (reliability). The manual
search of the Reference sections did not identify any
additional reports.
Table I (hip OA5e10) and Table II (knee OA6,7,11e23)
show the cut-offs reported in the articles on RCT and
epidemiological studies. Table III shows the cut-offs based
on predictive validity24e26. Table IV (hip27e33) and Table V
(knee OA34e49) show SDDs based on the BlandeAltman
reliability method. Only studies reporting SDD are shown.
Studies that reported cut-offs based on the CV are not
shown because this procedure is not recommended as
discussed below. The quality of selected manuscripts
(reporting a cut-off for JSW expressed in millimeters)
was assessed using the 2006 impact factors. These arti-
cles were published in various journals with a mean SD
impact factor of 6.39 2.12 (hip) and 6.78 4.96 (knee).EXPERT’S OPINIONTable VI summarizes the outcome of the panel’s discus-
sion, that is, a consensus based on the expert opinion of the
researchers after reviewing the results of the systematic lit-
erature search.Table
Proposed cut-off values of radiological JSW in millimeters
Author Year Study* Cut-off mm Rationaley Study duration
Pavelka 2000 1 0.5 1 60
Chevalier 2001 2 0.6 2 12
Dougados 2001 1 0.5 2 36
Lane 2004 2 0.5 1 96
Reijman 2005 2 1 1 72
Reijman 2007 2 1 1 72
ITT: intent-to-treat population; Compl: completers’ population.
*Study: 1¼ randomized placebo controlled trial; 2¼ epidemiological st
yRationale: 1¼ arbitrary proposal; 2¼ proposal based on the reliability
zPatients: 1¼ population; 2¼ hip OA population; 3¼ hip OA painful-poDiscussionCHOICE OF MODALITYThe panel of experts conﬁrmed a previous decision by the
sub-task force on structure that structural progression of OA
should be evaluated via plainX-rays. At this time, only radiog-
raphy has been adequately validated to assessOA structural
progression in large multi-center phase III trials. The initial
sub-task force concluded in 20063 that other techniques
such as MRI pose difﬁcult practical issues in multi-center in-
ternational trials, such as lack of a validated scoring system
available in the public domain and insufﬁcient data concern-
ing metrological properties. The panel of experts agrees that
MRImight eventually be recommended to evaluate structural
change in hip and knee OA if these difﬁculties can be
resolved. The panel of experts also conﬁrmed the previous
decision to quantify change in JSW in millimeters.CHOICE OF JSW CRITERIAIt was agreed that results should be presented at the
individual level as a dichotomous variable (e.g., percentage
of ‘‘progressors’’) rather than at the group level using a con-
tinuous variable (e.g., mean changes in JSW) as being
more meaningful to clinicians. It was recognized that a cate-
gorical variable based on a cut-off in JSW would have less
statistical power than a continuous variable. However, a di-
chotomous variable (Radiological Progression: Yes/No) is
needed for the domain structure of the ﬁnal composite index
(planned set of criteria) even though it decreases statistical
power.
Thereafter, the panel of experts focused the discussion
on the relative interest of choosing an absolute cut-off
value at a certain point of time vs a change in the JSW
vs baseline. The group of experts further agreed that
the set of criteria to qualify for total articular replacement
in knee/hip OA should be based on change in JSW
(e.g., JSW change >0.5 mm) rather than absolute JSW
(e.g., JSW <1 mm) or relative change (e.g., change
>30%). This decision was mainly due to the potential
lack of clinical relevance of relative change from a small
baseline value (for example, a 33% decrease in two pa-
tients with a baseline JSW of 2.4 and 1.2 mm would be
0.8 and only 0.4 mm, respectively).I
used in RCT and epidemiological studies in hip OA
months Groups
Placebo Active
N % Progressors N (z) % Progressors
Compl ITT Compl ITT
60 62 22 60 (3) 24 10
29 (3) 34.1
225 62.3 60.4 221 (3) 50.7 47
745 (2) 46
1905 (1) 13.1
1676 (1) 8.7
udy.
of technique of measurement of JSW.
pulation.
Table II
Proposed cut-off values of radiological JSW in millimeters used in RCT and epidemiological studies in knee OA
Author Year Study* Cut-off mm Rationaley Study duration months Groups
Placebo Active
N % Progressors N (z) % Progressors
Compl ITT Compl ITT
Sharif 1995 2 2 1 60 94 (3) 27.6
Dieppe 1997 2 2 1 36 145 (3) 14.4
Pavelka 2000 1 0.5 1 60 140 31 20.8 140 (3) 36 26
Reginster 2001 1 0.5 1 36 106 42.2 30 106 (3) 22 15
Pavelka 2002 1 0.5 1 36 101 25.5 14 101 (3) 7.6 5
Mazzuca 2006 1 0.5 1 16 191 21.5 188 (3) 15.4
30 180 31.7 181 (3) 26.0
Mazzuca 2006 1 1.0 1 16 191 7.3 188 (3) 3.7
30 180 7.2 181(3) 9.4
Pham 2004 1 0.5 1 12 85 20.3 19.1 122 (3) 17.7 16.5
Pham 2004 1 0.5 1 24 74 37.2 26 82 (3) 43 29
Spector 2005 1 0.75 2 12 99 6 5 90 (3) 0 0
Mikesky 2006 1 0.5 2 30 60 41 ? 45 (2) 42 ?
Mazzuca 2006 2 0.5 2 30 267 (2) 31
Raynauld 2006 2 0.6 2 24 110 (3) 13
Bingham 2006 1 0.6 1 24 622 13 11.5 1861 (3) 13 12
Bruyere 2007 2 0.3 1 12 62 (2) 20.5
Reijman 2007 2 1 1 72 532 (2) 21.8
ITT: intent-to-treat population; Compl: completers’ population.
*Study: 1¼ randomized placebo controlled trial; 2¼ epidemiological study.
yRationale: 1¼ arbitrary proposal; 2¼ proposal based on reliability of technique of measurement of JSW.
zPatients: 1¼ population; 2¼ knee OA population; 3¼ knee OA painful-population.
860 P. Ornetti et al.: OARSIeOMERACT deﬁnition of radiological progression in hip/knee OACHOICE OF CUT-OFF METHODOLOGYThe panel felt that predictive validity would be the best
method to establish a cut-off deﬁning relevant structural
progression. However, they agreed that at the moment
there are not currently sufﬁcient published results on predic-
tive validity, in particular for knee OA. Thus, although clini-
cally relevant, it is therefore too early to recommend
change in JSW based on predictive validity as a criterion
to assess the relevance of structural progression. Conse-
quently, the panel recommended that radiological progres-
sion should be deﬁned in terms of measurement error,
i.e., a change greater than the combined variability in
repeating the imaging procedure and in the measurement
process itself.CALCULATION OF SDDThe committee recommended a cut-off for radiological
progression in terms of the SDD determined from the BlandTable III
Proposed cut-off values of radiological JSW in millimeters used in
studies based on predictive validity in hip and knee OA
Author Year Location Cut-off
mm
X-rays
interval*,
weeks
Study
durationy,
weeks
End-
pointz
Maillefert 2002 Hip 0.4 104 156 1
Maillefert 2002 Hip 0.4 104 0 2
Bruyere 2005 Knee 0.7 36 60 1
*X-ray interval¼ duration in weeks between the two ﬁlms.
yStudy duration¼ duration in weeks between the date of the
second X-ray and the time the end-point is collected.
zEnd-point: 1¼ total articular replacement; 2¼ expert opinion.and Altman method that requires calculation of the mean
and SD deviation of the difference in JSW between two suc-
cessive analyses. Radiological progression is deﬁned as
a change in JSW greater than the upper bound of the
two-sided 95% conﬁdence interval around the mean differ-
ence. Because of the numerous pitfalls associated with the
CV, the experts agreed to not recommend this statistical
technique.
However, the experts noted that several different proce-
dures used to measure JSW have been used to calculate
the SDD in the literature, all based on the BlandeAltman
approach, and that the resulting SDD values vary widely
among well-designed studies (0.22e0.78 for hip OA,
0.12e0.84 for knee OA). Such heterogeneity might be
explained by the fact that some studies evaluated the whole
process of data collection (i.e., from the patient’s positioning
to the scoring of the ﬁlm) while others evaluated a single
step of the procedure (e.g., scoring system). Furthermore,
the huge difference in the proposed cut-offs in epidemiolog-
ical studies vs in RCT is probably explained by the quality of
the ﬁlm.
According to the experts, the SDD to deﬁne a cut-off for
radiological progression should reﬂect the variability of all
facets of the radiological measurement (i.e., patient’s posi-
tioning, radiographic procedure and scoring system) and
not only one facet (e.g., scoring system). The patient should
come twice to the same department of radiology with a repo-
sitioning of both the machine and the patient between the
two examinations. Cut-offs deﬁned by such reproducibility
study are closely dependent on all sources of variability in
JSW measurement. Therefore, standardization of radio-
graphic procedure and joint positioning or improvement in
the scoring process are key factors in order to minimize
such cut-offs.
In light of the observed heterogeneity of SDD from study
to study, the panel of experts felt that a cut-off should apply
Table IV
Proposed cut-off values of radiological JSW in millimeters based on the measurement error (e.g., Bland and Altman method with SDD)
in hip OA
Author Year Analysis* Filmy Bland and Altman method
N Mean change SD change SDD mm (cut-off) Limits of agreement
Min Max
Dougados 1996 3 (52) 1 30 0.01 0.28 0.56 0.55 0.57
Auleley 1998 1 1 (standing) 46 0.02 0.11 0.22 0.2 0.24
1 1 (supine) 46 0.002 0.13 0.26 0.262 0.258
Auleley 2001 2 1 37 0.02 0.23 0.46 0.48 0.44
Conrozier 2001 1 1 28 0 0.15 0.3 0.3 0.3
Maillefert 2002 3 (156) 1 35 0.028 0.39 0.78 0.752 0.808
3 (156) 1 (computer) 35 0.077 0.34 0.67 0.593 0.747
Hilliquin 2002 1 1 100 0.03 0.22 0.44 0.47 0.41
Maheu 2005 3 (156) 1 50 0.02 0.18 0.37 0.35 0.39
3 (156) 2 50 0.03 0.16 0.31 0.28 0.34
3 (156) 3 50 0.03 0.16 0.31 0.28 0.34
*Analysis: 1¼ score of a single ﬁlm in a single patient; 2¼ score of two ﬁlms in a single patient taken less than 2 days a part; 3¼ score of
the changes in a single patient between two visits and () the number of weeks between these two visits.
yFilm: 1¼ pelvic; 2¼ hip AP; 3¼ hip lateral.
861Osteoarthritis and Cartilage Vol. 17, No. 7only to the population that was sampled to determine the
SDD, using the same radiographic procedure, the same
measuring instrument and reader. It is therefore appropri-
ate, before beginning any study of a DMOAD, to conduct
a pilot study to evaluate the SDD in a sub-group of patients
with similar characteristics to the patients who will be en-
rolled in the study, particularly in terms of baseline JSW.
The centers participating in the SDD pilot study should
also be representative of those participating in the main
study, and should not all be the most experienced centers.
As regards progression deﬁned as the JSW exceeding
some cut-off based on the SDD, the experts underlined
that the probability of progressing clearly increases with lon-
ger patient follow-up. Given the potentially low probability of
progression with a short follow-up, there are two options to
demonstrate a statistically signiﬁcant effect of an experi-
mental DMOAD:
e A larger sample size and a short follow-up. This sce-
nario has the advantage of minimizing loss of patients
to follow-up.Table V
Proposed cut-off values of radiological JSW in millimeters based on the
SDD in kne
Author Year Analysis* Filmy
N Mean ch
Ravaud 1996 3 (52) 1 55 0.01
1 1 55 0.2
Ravaud 1998 2 1 36 0.03
Mazzucca 2002 2 1 76 0
Buckland- Wright 2003 2 1 266 0.01
Vignon 2003 1 2 36 0
Conrozier 2004 1 1 (semi-auto) 127 0.01
1 1 (auto) 127 0.00
Lavalley 2005 2 3 355 0.01
*Analysis: 1¼ score of a single ﬁlm in a single patient; 2¼ score of two
the changes in a single patient between two visits and if yes precise () th
yFilm: 1¼ antero-posterior view; 2¼ ﬂexed view; 3¼ lateral view.e A longer follow-up. This option is more consistent with
the natural history of the disease (i.e., a slow process
which can be modiﬁed only by a ‘‘substantial’’ period
of treatment).
This study was conducted to develop a deﬁnition of radio-
logical progression of hip and knee OA based on both the
Evidence Based Medicine (Systematic Literature Search)
and Expert Opinion approach. This initiative is part of
a larger initiative to develop a set of criteria that would qual-
ify a subject for total articular replacement. Satisfaction of
these criteria could be an end-point in clinical trials evaluat-
ing potential DMOADs.
Neither the systematic literature research nor consider-
ation of expert’s opinion yielded unique and universal
JSW change cut-offs for either hip OA or knee OA that
clearly identiﬁed progressors. Instead, the panel proposed
that a cut-off should be determined for each study based
on a pilot study that assesses the inherent variability of
the measurement process in a representative sample of
the studied population. The cut-off should be the SDDmeasurement error (e.g., Bland and Altman method with
e OA)
Bland and Altman method
ange SD change SDD mm (cut-off) Limits of agrements
Min Max
0.43 0.84 0.85 0.83
0.33 0.64 0.44 0.84
0.32 0.62 0.65 0.59
0.3 0.6 0.6 0.6
2 0.169 0.33 0.342 0.318
0.25 0.5 0.5 0.5
0.14 0.27 0.26 0.28
5 0.06 0.12 0.115 0.125
0.43 0.84 0.85 0.83
ﬁlms in a single patient taken less than 2 days a part; 3¼ score of
e number of weeks between these two visits.
Table VI
OARSIeOMERACT definition of relevant structural progression in
hip/knee OA
1 Structural progression is optimally deﬁned by plain radiologi-
cal evaluation of JSW in millimeters
2 The results of the analysis of JSW should be expressed in
terms of a dichotomous variable (e.g., progressors yes/no)
3 An absolute change in JSW over a predeﬁned threshold is
deﬁning a progressor.
4 The threshold above which a change in JSW can be consid-
ered as relevant should be based on the evaluation of the
measurement error of the radiological technique.
5 The Bland and Altman technique is the most appropriate one
to evaluate the measurement error of the radiological tech-
nique evaluating JSW.
6 The pilot study aimed at evaluating the measurement error
should be designed to reﬂect the different characteristics of
the primary study in which the analysis of the radiological ﬁnd-
ings will be based on (patient’s characteristics, centers char-
acteristics, readers .).
862 P. Ornetti et al.: OARSIeOMERACT deﬁnition of radiological progression in hip/knee OAcalculated from measurements using X-rays repeated over
a short period.
This approach to deﬁning progression should be revisited
as relevant results are obtained in ongoing and/or planned
studies in this ﬁeld.
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